mecamylamine has been researched along with Cerebral Concussion in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyeth, BG | 1 |
| Dixon, CE | 1 |
| Hamm, RJ | 1 |
| Jenkins, LW | 1 |
| Young, HF | 1 |
| Stonnington, HH | 1 |
| Hayes, RL | 1 |
1 other study available for mecamylamine and Cerebral Concussion
| Article | Year |
|---|---|
Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat.
Topics: Animals; Blood Pressure; Brain; Brain Concussion; Heart Rate; Male; Mecamylamine; N-Methylscopolamin | 1988 |